CTHRC1 and cancer: ANSIA-based stromal invasion analysis showed that silencing of the CTHRC1 in fibroblasts markedly increased cancer invasion, confirming its role as a contributor to stromal resistance characterizing cluster 5, which predominates the stromal fibroblast population in stage IIA, as cancer grows but is yet to disseminate.